Literature DB >> 2694076

Production and characterization of human monoclonal antibodies against Schistosoma mansoni.

A M Goes1, R S Rocha, G Gazzinelli, B L Doughty.   

Abstract

We have produced a panel of human monoclonal antibodies (MoAb) from patients infected with Schistosoma mansoni in order to analyse more carefully the human immune response to this helminth infection. This study describes the production, characterization and analysis of these MoAbs. Briefly, peripheral blood mononuclear cells from chronically infected patients were (1) isolated and stimulated with parasite antigens in vitro, (2) positively selected for B-cells on anti-Ig columns, and (3) then transformed with Epstein-Barr virus (EBV). Once EBV cell lines were established, they were selected for anti-S. mansoni antibodies using an ELISA, cloned, retested and then fused with the mouse-human heteromyeloma SHM-D33. In this study, we describe five MoAbs which have different antigenic specificities for life-cycle stages based on ELISA to soluble crude antigen preparations, membrane immunofluorescence on whole intact organisms, and immunofluorescent staining of cryostat frozen sections. The importance of these reagents with regard to the human immune response to S. mansoni is currently being evaluated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2694076     DOI: 10.1111/j.1365-3024.1989.tb00930.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  6 in total

Review 1.  Serodiagnosis of parasitic diseases.

Authors:  S E Maddison
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

2.  Mice lacking the gamma interferon receptor have an impaired granulomatous reaction to Schistosoma mansoni infection.

Authors:  S A Rezende; V R Oliveira; A M Silva; J B Alves; A M Goes; L F Reis
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

3.  Two distinct pathological syndromes in male CBA/J inbred mice with chronic Schistosoma mansoni infections.

Authors:  G S Henderson; N A Nix; M A Montesano; D Gold; G L Freeman; T L McCurley; D G Colley
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

4.  Oral vaccination based on DNA-chitosan nanoparticles against Schistosoma mansoni infection.

Authors:  Carolina R Oliveira; Cíntia M F Rezende; Marina R Silva; Olga M Borges; Ana P Pêgo; Alfredo M Goes
Journal:  ScientificWorldJournal       Date:  2012-04-22

5.  A new strategy based on SmRho protein loaded chitosan nanoparticles as a candidate oral vaccine against schistosomiasis.

Authors:  Carolina R Oliveira; Cíntia M F Rezende; Marina R Silva; Ana Paula Pêgo; Olga Borges; Alfredo M Goes
Journal:  PLoS Negl Trop Dis       Date:  2012-11-29

6.  Neonatal idiotypic exposure alters subsequent cytokine, pathology, and survival patterns in experimental Schistosoma mansoni infections.

Authors:  M A Montesano; D G Colley; S Eloi-Santos; G L Freeman; W E Secor
Journal:  J Exp Med       Date:  1999-02-15       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.